For research use only
| Cat No. | ABC-TC0363 |
| Product Type | Human Bone Cancer Cell Lines |
| Cell Type | Fibroblast-like |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Muscle |
| Disease | Extraskeletal Myxoid Chondrosarcoma |
| Product Code | HEMCSS; HEMC-SS |
H-EMC-SS cell line is a human soft tissue sarcoma model used in drug response testing and mechanistic studies of tumor progression and signaling.
H-EMC-SS is a human extraskeletal myxoid chondrosarcoma cell line derived from muscle tissues of a female patient. This cell line exhibits mixed epithelial-like and spindle-shaped morphology, adheres as monolayers in culture, and demonstrates a stable doubling time. It maintains microsatellite stability and displays moderate migratory behavior, making it suitable for studying sarcoma biology, metastasis, and drug response. Its reproducible growth characteristics and consistent performance in various in vitro assays have established it as a reliable model for translational research, particularly in evaluating novel therapeutic strategies and chemoresistance in sarcomas. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HEMCSS; HEMC-SS |
| Species | Human |
| Cat.No | ABC-TC0363 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast-like |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Muscle |
| Disease | Extraskeletal Myxoid Chondrosarcoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Bone Cancer Cell Lines |
H-EMC-SS cell line is well-suited for studies of extraskeletal myxoid chondrosarcoma tumor biology, including exploration of cellular migration, invasion, and response to targeted therapies. These adherent cells reflect sarcoma tumor morphology and behavior under laboratory conditions. They can be used in drug screening platforms to identify candidate compounds inhibiting sarcoma cell growth or metastasis, as well as in pathway analysis of cytogenetic translocations typical of sarcoma.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
